We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Regulatory capacity building and the governance of clinical stem cell research in China.
- Authors
Sleeboom-Faulkner, Margaret; Haidan Chen; Rosemann, Achim
- Abstract
While other works have explained difficulties in applying 'international' guidelines in the field of regenerative medicine in so-called low- and middle-income countries (LMICs) in terms of 'international hegemony', 'political and ethical governance' and 'cosmopolitisation', this article on stem cell regulation in China emphasizes the particular complexities faced by large LMICs: the emergence of alternative regulatory arrangements made by stakeholders at a provincial level at home. On the basis of ethnographic and archival research of clinical stem cell research hubs, we have characterized six types of entrepreneurial 'bionetworks', each of which embodies a regulatory orientation that developed in interaction with China's regulatory dilemmas. Rather than adopting guidelines from other countries, we argue that regulatory capacity building is more appropriately viewed as a relational concept, referring to the ability to develop regulatory requirements that can cater for different regulatory research needs on an international level and at home.
- Subjects
REGULATORY approval; STEM cells; MEDICAL research; HEGEMONY; TECHNOLOGICAL innovations
- Publication
Science & Public Policy (SPP), 2018, Vol 45, Issue 3, p416
- ISSN
0302-3427
- Publication type
Article
- DOI
10.1093/scipol/scx077